Vincent J. Milano
2018
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $998,081 |
| Salary | $600,000 |
| Other | $33,863 |
| Total | $1,781,944 |
Milano received $998.1K in option awards, accounting for 56% of the total pay in 2018.
Milano also received $150K in non-equity incentive plan, $600K in salary and $33.9K in other compensation.
Rankings
In 2018, Vincent J. Milano's compensation ranked 6,318th out of 14,244 executives tracked by ExecPay. In other words, Milano earned more than 55.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,318 out of 14,244 | 56th |
Division Manufacturing | 2,421 out of 5,765 | 58th |
Major group Chemicals And Allied Products | 901 out of 2,128 | 58th |
Industry group Drugs | 756 out of 1,817 | 58th |
Industry Biological Products, Except Diagnostic Substances | 147 out of 339 | 57th |
Pay ratio
| Vincent J. Milano's Pay | $1,781,944 |
|---|---|
| Median Employee's Pay | $297,391 |
| Pay Ratio | 6to 1 |
In 2018, the annual total compensation of Vincent J. Milano was $1,781,944.
The annual total compensation of the median employee at Idera Pharmaceuticals was $297,391.
The ratio of Vincent J. Milano's pay to the pay of median employee was therefore 6 to one.
Milano's colleagues
We found six more compensation records of executives who worked with Vincent J. Milano at Idera Pharmaceuticals in 2018.
2018
Joanna Horobin
Idera Pharmaceuticals
Chief Medical Officer
2018
Louis Arcudi
Idera Pharmaceuticals
Chief Financial Officer
2018
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
2018
Jonathan Yingling
Idera Pharmaceuticals
Chief Scientific Officer
2018
Bryant Lim
Idera Pharmaceuticals
General Counsel
2018
John Kirby
Idera Pharmaceuticals